Malignancy risk stratification prediction of BI-RADS 4B calcifications based on contrast-enhanced mammographic features: a multicenter study
Authors:
Open Access
- 21 November 2024
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 210 (1) , 135-145
Abstract
Purpose This study aims to investigate the factors influencing the malignant risk of BI-RADS 4B calcification-only lesions detected on Contrast-Enhanced Mammography (CEM) and to develop a predictive model for stratifying malignant risk. Methods A retrospective analysis was conducted on 131 calcification-only lesions of BI-RADS 4B identified on low-energy (LE) images of CEM from 125 females between March 2017 and April 2023 at three institutions. The patients were grouped as training (95 lesions) and external validation sets (36 lesions). On LE images, morphological features of the calcifications, including morphology, distribution and size, were evaluated. On recombined images, the presence and types of enhancement were assessed as qualitative variables, and the grey values from lesion areas and background were measured as quantitative variables. Multivariate logistic regression analysis was used to construct a predictive model. The discrimination of the model was assessed by the receiver operating characteristic (ROC) curve and confirmed by the external validation set. Results Of the 131 lesions, 43 were malignant. The morphology, distribution, the presence and types of enhancement and the grey values of calcifications showed significant differences between benign and malignant lesions. The nomogram was developed based on morphology and the presence of enhancement, with areas under the ROC curve of 0.859 (95% confidence interval [CI]: 0.769, 0.949) and 0.856 (95% CI: 0.729, 0.983) in the training and external validation sets, respectively. Conclusion On CEM, the presence of enhancement and morphology were identified as independent predictors of malignant calcifications of BI-RADS 4B. The predictive model demonstrated favorable performance.Keywords
Funding Information
- Science Foundation of Peking University Cancer Hospital (2020-24, XKFZ2403)
- National Key Research and Development Program of China (2023YFC3402805)
This publication has 26 references indexed in Scilit:
- Evaluation of Malignancy Risk Stratification of Microcalcifications Detected on Mammography: A Study Based on the 5th Edition of BI-RADSAnnals of Surgical Oncology, 2015
- A Comparative Study of the Diagnostic Value of Contrast-Enhanced Breast MR Imaging and Mammography on Patients with BI-RADS 3–5 MicrocalcificationsPLOS ONE, 2014
- Evaluation of the Role of Dynamic Contrast-Enhanced MR Imaging for Patients with BI-RADS 3–4 MicrocalcificationsPLOS ONE, 2014
- Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programmeEuropean Radiology, 2014
- 3-T breast magnetic resonance imaging in patients with suspicious microcalcifications on mammographyEuropean Radiology, 2013
- Comparison of Digital Screening Mammography and Screen-Film Mammography in the Early Detection of Clinically Relevant Cancers: A Multicenter StudyRadiology, 2012
- The Positive Predictive Value of BI-RADS Microcalcification Descriptors and Final Assessment CategoriesAmerican Journal of Roentgenology, 2010
- Meta-Analysis of MR Imaging in the Diagnosis of Breast LesionsRadiology, 2008
- Mammographic Appearance of Nonpalpable Breast Cancer Reflects Pathologic CharacteristicsAnnals of Surgery, 2002
- MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast CancerRadiology, 2001